Cutaneous myiasis

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:99983B87.0
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Cutaneous myiasis is a parasitic skin infestation caused by the larvae (maggots) of various fly species that penetrate and develop within the skin and subcutaneous tissues. It is not a genetic disorder but rather an infectious/parasitic condition classified among rare dermatological diseases. The condition primarily affects the integumentary system (skin) and can occur in several forms: furuncular myiasis (boil-like lesions, most commonly caused by Dermatobia hominis, the human botfly, or Cordylobia anthropophaga, the tumbu fly), creeping/migratory myiasis (caused by larvae tunneling through the skin), and wound myiasis (larvae infesting open wounds). Cutaneous myiasis is most prevalent in tropical and subtropical regions of Central and South America, sub-Saharan Africa, and parts of Asia, though cases can occur worldwide, particularly among travelers returning from endemic areas. Key symptoms include the development of one or more painful, erythematous, furuncle-like nodules in the skin, often with a central punctum or pore through which the larva breathes. Patients frequently report a sensation of movement beneath the skin, pruritus (itching), and serous or serosanguinous discharge from the lesion. Secondary bacterial infection may complicate the condition, leading to increased pain, swelling, and purulent drainage. Regional lymphadenopathy may also occur. The lesions most commonly appear on exposed areas of the body, including the scalp, face, arms, and legs. Treatment of cutaneous myiasis involves removal of the larva, which can be accomplished through several methods. Occlusive techniques—such as applying petroleum jelly, bacon strips, or adhesive tape over the punctum—suffocate the larva and encourage it to migrate toward the skin surface, facilitating extraction. Surgical extraction under local anesthesia may be necessary for deeply embedded larvae. Ivermectin has been used as an adjunctive treatment in some cases. Following larval removal, wound care and antibiotics may be prescribed if secondary infection is present. The prognosis is generally excellent once the larva is completely removed, with full resolution of symptoms expected.

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Cutaneous myiasis.

View clinical trials →

No actively recruiting trials found for Cutaneous myiasis at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Cutaneous myiasis community →

No specialists are currently listed for Cutaneous myiasis.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Cutaneous myiasis.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Cutaneous myiasisForum →

No community posts yet. Be the first to share your experience with Cutaneous myiasis.

Start the conversation →

Latest news about Cutaneous myiasis

No recent news articles for Cutaneous myiasis.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Cutaneous myiasis

What is Cutaneous myiasis?

Cutaneous myiasis is a parasitic skin infestation caused by the larvae (maggots) of various fly species that penetrate and develop within the skin and subcutaneous tissues. It is not a genetic disorder but rather an infectious/parasitic condition classified among rare dermatological diseases. The condition primarily affects the integumentary system (skin) and can occur in several forms: furuncular myiasis (boil-like lesions, most commonly caused by Dermatobia hominis, the human botfly, or Cordylobia anthropophaga, the tumbu fly), creeping/migratory myiasis (caused by larvae tunneling through t